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Glimepiride (GMP) is often combined with metformin 
HCl (MET) as an oral antidiabetic in type II diabetes 
mellitus (T2DM), which provides complementary and 
synergistic effects with the dual goal of improving insulin 
secretion and insulin action in tissues1. Glimepiride 
includes in biopharmaceutics classification system (BCS) 
class II, which has low solubility but high permeability 
with practically insoluble solubility data in water, so that 
it will have an impact on the small bioavailability of the 
drug. In contrast, MET includes in BCS class III, which 
has a high solubility in water, but has low permeability, 
which is about 50-60% absorbed in the gastrointestinal 
tract given orally2,3. 
Sanofi Aventis has produced GMP and MET in a fixed-
dose combination (Amaryl M®) tablet dosage form, 
which is an innovator product4. However, some 
pharmaceutical manufacturers that make copy product 
of GMP and MET are constrained in producing tablet 
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Glimepiride is often combined with metformin HCl as an oral 
antidiabetic in type II diabetes mellitus, which provides a 
complementary and synergistic effect with multiple targets for insulin 
secretion. Glimepiride includes class II of BCS, which solubility 
practically insoluble in water but high permeability, which will impact 
the drug's small bioavailability. In contrast, metformin HCl includes 
class III of BCS, which has a high solubility in water, but low 
permeability is absorbed approximately 50-60% in the digestive tract 
given orally. The co-crystallization method can be used to improve the 
glimepiride solubility properties and the permeability properties of 
metformin HCl by interrupting glimepiride with metformin HCl 
physically. This study aims to identify the physical interactions 
between glimepiride and metformin HCL using a thermal analysis of 
Differential Scanning Calorimetry (DSC) and then confirmed by a 
computational approach. Identifying the physical interactions 
between glimepiride and metformin HCL was carried out by plotting 
the melting points generated from the endothermic peaks of the DSC 
thermogram at various compositions versus the mole ratios of the two 
were further confirmed by the computational approach using 
PatchDock. The results of the phase diagram analysis of the binary 
system between glimepiride and metformin HCl show a congruent 
pattern, which indicates the formation of co-crystal or molecular 
compounds at a 1 : 1 mole ratio at 228°C. Computational approach 
results showed that the interaction between glimepiride and 
metformin HCl did not form new compounds but heterosinton 
formation that was stable in molecular dynamics simulations. 
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preparations that meet quality requirements so that 
efforts need to be made to increase the solubility of GMP 
as well as the permeability of MET by physically 
interacting GMP with MET through the cocrystallization 
method5,6. Cocrystallization is a physical method based 
on the combination of active pharmaceutical ingredients 
acting as a host with co-formers acting as guests through 
hydrogen bonds or Van der Waals in the same crystal 
lattice7,8. 
Studies on the identification of the type of interaction 
between GMP and MET have not been previously 
reported. For this reason, it is necessary to identify the 
physical interactions that occur between GMP and MET 
using thermal analysis differential scanning calorimetry 
(DSC), the results of which are then constructed in the 
form of a phase diagram of the GMP-MET binary 
system9,10. Furthermore, the resulting physical 
interactions were confirmed by the computational 
approach using docking simulations methods, molecular 
dynamics simulations, and MM/PBSA binding-free 
energy calculations11,12. 
 
MATERIALS AND METHODS 
Materials 
The material used were glimepiride (Glenmark, India) 
and metformin hydrochloride (Hildose, India). The 
instruments used include DSC-Thermogravimetric 
analysis (DSC-TGA STA PT1600, LINSEIS Thermal 
Analysis), analytical scales (Mettler Toledo AG204), 
vortex mixer (JEIO Tech) and microtube (Eppendorf). 
The in silico study was conducted with a computer with 
an Intel® Core i3-6100 CPU @ 2.30 GHz (4 CPUs) 
specification, 4096 MB RAM, 320 GB hard drive, and 
VGA Intel HD Graphics 520. The software used includes 
Quantum ESPRESSO v.6.6, PatchDock web server 
(https://bioinfo3d.cs.tau.ac.il/PatchDock/php.php), 
Gromacs 2016.3, VMD 1.9.4, and BIOVIA Discovery 
Studio Visualizer v16.1.0.15350. 
Methods 
Molecular structure modeling and optimization 
The molecular structure of GMP and MET was modeled 
in two-dimensional using the BIOVIA Discovery Studio 
Visualizer v16.1.0.15350, which downloaded from the 
PubChem website in National Center for Biotechnology 
Information (https://pubchem.ncbi.nlm.nih.gov/) as 
shown in Figure 1. Optimization of the molecular 
structure of the GMP and MET was performed using the 
Quantum ESPRESSO v.6.6 with density functional 





Figure 1. The two-dimensional structure of (a) GMP and (b) 
MET 
 
Glimepiride-metformin complex formation simulations 
The optimized GMP and MET compounds were then 
simulated for complex formation. This complex 
formation simulation was accomplished using the 
PatchDock web server according to the procedure 
reported by Fakih et al15. 
Identification of glimepiride-metformin interactions 
The molecular interactions formed between GMP and 
MET molecules were then identified using the BIOVIA 
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Discovery Studio Visualizer v16.1.0.15350 according to 
the procedure reported by Fakih et al15. 
Glimepiride-metformin interaction dynamics 
Interaction dynamics simulations were performed using 
Gromacs 2016.3 to observe and identify the stability of 
GMP and MET. Electrostatic forces were selected using 
the Particle Mesh Ewald method. Neutralization of the 
system was carried out by adding Na+ and Cl- ions. 
Solvation was determined using the TIP3P water model. 
The simulation preparation stage includes minimization, 
heating to 310 K, temperature equilibration, pressure 
equilibration, and a 500 ns production run with a 2 fs 
timestep15,16. 
MM/PBSA end-point binding-free energy calculations 
The Molecular Mechanics/Poisson-Boltzmann Surface 
Area (MM/PBSA) binding-free energy calculations were 
accomplished by the g_mmpbsa package integrated into 
the Gromacs 2016.3. The polar desolvation energy was 
calculated using the Poisson-Boltzmann equation with a 
grid size of 0.5 Å. The dielectric constant of the solvent 
was set to 80 to represent water as the solvent. The non-
polar contribution was determined by calculating the 
surface area accessible to the solvent with a radius of 1.4 
Å17-19. 
Preparation of glimepiride-metformin physical mixtures 
Preparation of the physical mixture of GMP-MET was 
carried out by weighing GMP and MET at various 
compositions based on the mole ratio between the two, 
which was carried out for three replications. It was 
known that the molecular weights of GMP and MET 
were 490.62 g/mol and 165.63 g/mol, respectively. 
Furthermore, thermal analysis was carried out using the 
DSC method to obtain the melting point of the 
endothermic peak of the DSC thermogram, which was 
constructed into a phase diagram of the GMP-MET 
binary system21. 
RESULTS AND DISCUSSION 
Glimepiride-metformin binary mixtures 
Preparation of the GMP-MET binary mixture aims to 
identify the interactions between GMP and MET at 
various compositions based on their molecular ratios, 
whether the cocrystal phase (molecular compound) or a 
simple eutectic mixture was formed as well as its 
molecular ratio, as shown in Table I. This binary mixture 
was thermally analyzed using the DSC method so that 
the melting point from the endothermic peak of the DSC 
thermogram was obtained, as presented in Table II. 
Then, it was constructed into a binary system phase 
diagram by plotting the resulting melting points of the 
endothermic peak of the DSC GMP-MET thermogram at 
various compositions versus the mole ratio of the two, as 
presented in Figure 2. 
The results of the phase diagram analysis of the GMP-
MET binary system show a congruent pattern that 
indicates the formation of cocrystal or molecular 
compounds. The physical mixture of GMP-MET showed 
this phenomenon at a mole ratio of 1 : 1 (GM 7), which 
had two endothermic peaks at a temperature of 196.6°C 
and 228°C. 228°C was the highest melting temperature 
between the melting temperatures of GMP and MET of 
pure forms were 205.8°C and 235.1°C, respectively22. 
If the two components form the compound of molecular, 
it would be flanked by two temperature melting 
compound called eutectic point (TE), TA and TB was the 
melting temperature of each pure components of GMP 
and MET, when the temperature was plotted based on 
the composition of the mixture of components would be 
obtained a TA-TE-TC-TE-TB track called the liquidus curve. 
Above the liquidus curve, GMP and MET were in the 
liquid phase, and the two components of the compound 
dissolve with each other22,23. 
The highest melting point was TC of the liquidus curve, 
which was the point of formation of molecular 
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compounds, while the lowest melting point is TE of the 
liquidus curve, which was the eutectic point. At TC point, 
two components, A and B, were melted together 
(congruent) without changing the composition of the two 
components at the same highest temperature and the 
liquid phase was in equilibrium with the solid phase. 
Under the liquidus curve, each component A and B was 
in a solid state and did not dissolve in one another25. 
Whereas in the GMP-MET physical mixture, the mole 
ratio of 1 : 9 (GM 3), 2 : 8 (GM 4), and 3 : 7 (GM 5) also had 
two endothermic peaks, in which the melting 
temperature at the second endothermic peak was lower 
than the physical mixture GMP- MET mole ratio was 1 : 
1 (GM 7). Therefore, it was not a point of formation of 
molecular or cocrystal compounds, but this 
phenomenon was only partial, meaning that the physical 
mixture of GMP-MET in these three ratios did not melt 
together26. 








GMP MET GMP-MET 
GM 1 1 : 0 490.62 0 490.62 
GM 2 0 : 1 0 165.63 165.63 
GM 3 1 : 9 490.62 1490.67 1981.29 
GM 4 2 : 8 981.24 1325.04 2306.28 
GM 5 3 : 7 1471.86 1159.41 2631.27 
GM 6 4 : 6 1962.48 993.78 2956.26 
GM 7 5 : 5 2453.1 828.15 3281.25 
GM 8 6 : 4 2943.72 662.52 3606.24 
GM 9 7 : 3 3434.34 496.89 3931.23 
GM 10 8 : 2 3924.96 331.26 4256.22 
GM 11 9 : 1 4415.58 165.63 4581.21 
 
Table II. Melting point recapitulation of the endothermic 





(GMP : MET) 
Melting point (°C) 
1 2 
GM 1 1 : 0 205.8 - 
GM 2 0 : 1 235.1 - 
GM 3 1 : 9 191.2 223.6 
GM 4 2 : 8 197.9 218.4 
GM 5 3 : 7 201.8 216.2 
GM 6 4 : 6 194.4 - 
GM 7 5 : 5 196.6 228 
GM 8 6 : 4 195.7 -  
GM 9 7 : 3 186.4 - 
GM 10 8 : 2 198.7 - 
GM 11 9 : 1 201.5 - 
 
Figure 2. Phase diagram of GMP-MET binary systems. 
TA: Melting point of GMP; TB: Melting point of MET; TC: Cocrystal point; 
TE: Eutectic point. 
Mole ratio: 0 = GMP : MET (1 : 0); 1 = GMP : MET (9 : 1); 2 = GMP : MET 
(8 : 2); 3 = GMP : MET (7 : 3); 4 = GMP : MET (6 : 4); 5 = GMP : MET (5 : 5); 
6 = GMP : MET (4 : 6); 7 = GMP : MET (3 : 7); 8 = GMP : MET (2 : 8); 9 = 
GMP : MET (1 : 9); 10 = GMP : MET (0 : 1) 
 
 
Computational approach of glimepiride-metformin 
The computational approach was demonstrated to 
identify and confirm the physical interactions between 
GMP and MET. Figure 3 shows that the interaction 
between GMP and MET did not form new compounds. 
However, the interaction that occurs was the formation 
of hydrogen bonds with heterosinton formation (Table 
III), as well as Van der Waals bonds were minimal, with 
a total energy of -0.00096 Å and a binding-free energy 
value of -415.35 kJ/mol. This binding-free energy 
produces a negative value which indicates a physical 
interaction between GMP and MET compounds that 
occurred spontaneously27. 
Overall poses of GMP and MET complexes changed 
during the simulation. However, based on the snapshots 
taken at 125, 250, 375, and 500 ns from the molecular 
dynamics simulation results, only slight conformational 
changes were observed (Figure 4). It was predicted that 
this phenomenon would increase the ability of the GMP 
























Figure 3. The three-dimensional (a) and two-dimensional (b) 
interaction of GMP and MET in docking simulations 
 





















Figure 4. GMP (red) and MET (green) conformation snapshots 
at 125, 250, 375, and 500 ns 
The root-mean-square deviation (RMSD) values of GMP 
and MET were calculated to ensure the stability and 
rationality of the selected conformations. Figure 5 shows 
that the complex formed fluctuates from 0 ns until 100 
and 300 ns. Nevertheless, at the end of the complex 
simulation, the GMP and MET began to achieve 
stability29. The average RMSD value during the 
molecular dynamics simulation was in the range of 2.04 
Å. 
 
Figure 5. RMSD value during molecular dynamics simulation 
 
The MM/PBSA free-binding energy was calculated 
based on the trajectory from the beginning to the end of 
the molecular dynamics simulation. Based on the 
MM/PBSA calculation results, it could be observed that 
the complex system had good binding-free energy, with 
a value of -107.74 kJ/mol (Table IV). The energies that 
contribute the most during the simulation were Van der 
Waals and electrostatic interactions. This was because the 
MM/PBSA approach allows observation of the influence 
of the contribution of Van der Waals and electrostatic and 
conformational changes that were influenced by the 
solvation process29. 











-125.03 -37.45 66.78 -12.04 -107.74 
∆EVdW: Van der Waals contribution; ∆Eele: electrostatic contribution; ∆GPB: 
polar contribution of desolvation; ∆GNP: non-polar contribution of 
desolvation; ∆GBind: ∆EVdW + ∆Eele + ∆GPB + ∆GNP 
 
125 ns 250 ns 








Metformin Hydrochloride (MET) 
Glimepiride (GMP) 
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CONCLUSION 
The identification results showed the presence of a co-
crystal (molecular compound) interaction of glimepiride-
metformin HCl at a 1 : 1 mole ratio and the formation of 
hydrogen bonds with heterosinton formation from 
docking simulations results which showed in binding-
free energy of -415.35 kJ/mol. Especially, the complex 
system is stable in molecular dynamics simulations with 
an average RMSD value of 2.04 Å and a calculated 
MM/PBSA value of -107.74 kJ/mol. 
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